<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report a case of cytomegalovirus (CMV) <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> after placement of a fluocinolone acetonide (Retisert) implant </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Interventional case report </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Retrospective chart review </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A 65-year-old man with a history of <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Adamantiades-Behcet disease</z:e> and bilateral recurrent <z:hpo ids='HP_0000554'>uveitis</z:hpo> that was unresponsive to systemic <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>-sparing immunosuppressive therapy developed clinical evidence of <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> after receiving his second intravitreal Retisert implant in the left eye, while on no systemic immunosuppression </plain></SENT>
<SENT sid="4" pm="."><plain>He did not develop <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> in the right eye despite multiple intraocular and periocular steroid injections </plain></SENT>
<SENT sid="5" pm="."><plain>The patient responded well to intravitreal foscarnet followed by placement of an intravitreal <z:chebi fb="0" ids="465284">ganciclovir</z:chebi> implant </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Ophthalmologists should be aware of the potential risk for development of <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> after local ocular immunosuppressive therapy </plain></SENT>
</text></document>